MORE►
biotech
The main building at Pegasus Park.[Image: GFF]
Renovations Begin for BioLabs’ December Opening at Pegasus Park
by Alex Edwards | Aug 10, 2021
A mid-December opening is planned for BioLabs' first central U.S. location in Dallas. Inside the Biotech+ Hub at Pegasus Park, BioLabs will serve as the key operator of the biotech laboratory and 37,000-square-foot flexible life science coworking facility.
by David Seeley |
Jun 22, 2021
Nanoscope Therapeutics successfully treated 11 patients blinded by advanced retinitis pigmentosa (RP). A single intravitreal injection produced positive results that persisted through one year. The startup plans a Phase 2b trial this summer and plans to develop gene therapies to treat more common retinal diseases—like dry age-related macular degeneration.
MORE►
by Alex Edwards |
Jun 17, 2021
The investment was led by Advantech Capital, a PE fund based in China that focuses on TMT, pharmaceuticals, and healthcare. This combined with the support from the Cancer Prevention and Research Institute of Texas (CPRIT), which granted OncoNano $9.97 million last year, will support Phase 3 clinical trials for the biotech's technology that can diagnose and treat cancer with high specificity.
MORE►
by Alex Edwards |
Mar 8, 2021
As CMO at the Dallas-based biotech, Jessica Hilton is part of a team working to launch the first-ever long-lasting cleaner that can fight COVID-19. It's a job she took during the middle of the global pandemic—and though her home life looks a little different, the mom of three is managing it all through a deep-seeded passion and supportive family.
MORE►
Doloromics Co-Founders Candler Paige, Dr. Theodore Price, and Jackson Brougher [Photos: Doloromics]
‘Highly Selective’ Illumina Accelerator Picks Dallas-Based Doloromics for its Second Funding Cycle
by Alex Edwards | Feb 16, 2021
Doloromics, a local therapeutics discovery startup that uses technology to find better ways to treat chronic pain, is one of nine companies selected.
MORE►
by Quincy Preston and Sandra Engelland |
Feb 11, 2021
Here are 32 North Texas startups that successfully pulled in capital to back their ventures.
Fitting the digital demands of a global pandemic, it's a tech-heavy group, with liberal doses of biotech and healthcare-related firms.
MORE►
by Alex Edwards |
Feb 10, 2021
The agreement will involve the two companies providing educational programs and connections for scientist entrepreneurs located at the Biotech+ Hub at Pegasus Park.
MORE►
by Lauren Hawkins |
Dec 8, 2020
Dallas life science startups are invited to apply to ThinkLab's winter cohort, which will begin in late January 2021.
MORE►
The Eos Bioreactor sequesters carbon dioxide using algae. [Photo: Courtesy Hypergiant Industries]
The Art of Climate Tech: Fort Worth Museum Showcases Hypergiant’s AI-Powered, Carbon-Capturing Eos Bioreactor
by Sandra Engelland | Nov 10, 2020
The Eos Bioreactor, which also has been featured in Popular Mechanics, uses algae to "eat" CO2.
MORE►
by Lauren Hawkins |
Oct 27, 2020
The Dallas-based leader will receive the award from BionorthTX for his contributions to the field of life sciences.
MORE►
by Alex Edwards |
Oct 27, 2020
The growth capital will allow Caris to advance its position as a leading tumor profiling company that aims to reinvent cancer care.
MORE►
by Quincy Preston |
Oct 8, 2020
This year's Nobel Prize in Chemistry, awarded to two female scientists for the development of CRISPR as a gene-editing tool, is a revolution, according to a pair of UTSW scientists.
UTSW's Eric Olson and Rhonda Bassel-Duby use the technology in their work to treat Duchenne muscular dystrophy. Olson also is the co-founder of biotech Exonics Therapeutics, which exited last year in a deal roughly valued at $1B.
MORE►
Photo: gopixa/iStock
Gates Foundation Scientist Joins Dallas Philanthropist to Talk Status of COVID-19 Vaccine—and Biotech in DFW
by Gloria Salinas, Managing Director, Economic Development, DRC | Oct 1, 2020
Dr. Lynda Stuart of the Bill & Melinda Gates Foundation talked with philanthropist and entrepreneur Lyda Hill in a virtual discussion moderated by Nicole Small, CEO of LH Capital/Lyda Hill Philanthropies.
Here's the takeaway.
Here's the takeaway.
MORE►
![At the Fourth Annual iC3 Life Science Summit at UT Arlington on Oct. 10, 2017 recipient Lyda Hill will present the award. To register for the summit, visit www.bionorthtx.org. [Illustration: bestbrk/istockphoto]](https://s24806.pcdn.co/wp-content/uploads/2018/09/Bionorthconcept_970_bestbrk_istockphotovector-molecule-background-genetic-and-chemical-compounds-abstract-vector-id908258902-360x203.jpg)
by Quincy Preston |
Sep 22, 2020
Networking—always a highlight of the biotech event— is still a cornerstone thanks to a new virtual conference platform, its organizers said.
MORE►
by Alex Edwards |
Sep 17, 2020
Eyevance Pharmaceuticals, which develops and commercializes ophthalmic products, has been purchased for $225 million by Santen, a Japanese leader in ophthalmology. Eyevance will join Santen's U.S. organization.
MORE►
by Quincy Preston |
Aug 25, 2020
CerSci shareholders could net another $887 million in milestones and tiered royalties. The clinical-stage startup, which launched in 2015, is developing a new generation of non-opioid meds to treat acute and chronic pain.
MORE►
